HOUMAN ASHRAFIAN - LONDON

HOUMAN ASHRAFIAN - LONDON

.

Overview

PROFESSOR HOUMAN ASHRAFIAN is a Director from London. This person was born in February 1975, which was over 49 years ago. PROFESSOR HOUMAN ASHRAFIAN is British and resident in England. This company officer is, or was, associated with at least 8 company roles.
Companies associated with this officer had at least £17,062,154 shareholder value and £18,390,238 cash in recent accounts.
Their most recent appointment, in our records, was to MESTAG THERAPEUTICS LTD on 2020-04-17, from which they resigned on 2023-06-29.

Address

71, Kingsway
London
WC2B 6ST
England

Map

Company Appointments - Current and Previous

CompanyName Company Status Role Appointed Appointment Status Assets
MESTAG THERAPEUTICS LTD Active Director 2020-04-17 until 2023-06-29 RESIGNED
CELLINTA LTD Active Director 2020-03-10 until 2023-08-07 RESIGNED £5,228 equity
CYBELE THERAPEUTICS LTD Dissolved - no longer trading Director 2019-12-11 CURRENT £19,971 cash, £321,301 equity
KARUS THERAPEUTICS LIMITED Liquidation Director 2019-01-24 until 2023-07-12 RESIGNED £3,298,505 cash, £3,297,802 equity
TREX BIO LIMITED Liquidation Director 2018-01-30 until 2022-04-21 RESIGNED £15,071,762 cash, £13,437,823 equity
SV HEALTH MANAGERS LLP Active Llp Member 2018-01-12 until 2023-08-31 RESIGNED
ENARA BIO LIMITED Active Director 2016-11-08 until 2023-06-14 RESIGNED
SV HEALTH INVESTORS LLP Dissolved - no longer trading Llp Member 2016-10-03 CURRENT

Companies Controlled

Company Active from Level of control
TREX BIO LIMITED 2018-01-30 - 2018-06-05 Voting rights 25 to 50 percent
Right to appoint and remove directors
ENARA BIO LIMITED 2016-11-08 - 2017-12-18 Ownership of shares 75 to 100 percent
Voting rights 25 to 50 percent
SITRYX THERAPEUTICS LIMITED 2016-09-08 - 2018-01-23 Ownership of shares 75 to 100 percent
Voting rights 25 to 50 percent
SV HEALTH INVESTORS UK LIMITED 2022-02-02 - 2023-07-20 Ownership of shares 25 to 50 percent
Voting rights 25 to 50 percent
SV HEALTH INVESTORS UK LIMITED 2021-11-12 - 2021-11-12 Ownership of shares 25 to 50 percent
Voting rights 25 to 50 percent


Related People

Name Occupation Address No of Appointments
MRS SUSAN MARGARET SUNDSTROM Manager Alresford 7
DR LIAM THOMAS RATCLIFFE Venture Capital Didcot, England 4
WILLIAM ARTHUR BAINS Scientist Cambridge, England 9
MARTIN WILLIAM EDWARDS Director Southampton 2
DR STEPHEN JOSEPH SHUTTLEWORTH Consultant Bourne End, United Kingdom 4
SRINIVAS AKKARAJU Director Southampton 1
DR ARASU GANESAN Reader Southampton 1
ANN VERONICA HACKER Company Director Oxford 3
ANDREW MACKIE Pharmaceutical Manager London 1
PROFESSOR GRAHAM KEITH PACKHAM Scientist Southampton 2
WILLIAM DRUMMOND PARIS Region Head Abingdon, England 1
JAMES CHRISTOPHER TAYLOR Commercial Director Cambridge 3
JAMES PETER WILLCOCKS Company Director Oxford, United Kingdom 5
PROFESSOR GRAHAM JOHN BOULNOIS Consultant Manchester 13
MS CATHERINE ELIZABETH BINGHAM Venture Capitalist London, United Kingdom 1
TIMOTHY EDWARDS Company Director Didcot, United Kingdom 2
MR RONALD HUNT Venture Capitalist New York, United States 1
DR THOMAS PETER DYRBERG Venture Capital Investor 2900 Hellerup, Denmark 1
MR JAMES ALLISTER JOHN COSTINE Chief Financial Officer Belfast, Northern Ireland 4

Nearby People

Name Occupation Address No of Appointments
DR HAMISH ALAN CAMERON Biotech/Pharmaceutical Industry Consultant London 2
MR GILES EDWARD NAYLOR Lawyer London, United Kingdom 10
ACUMEN MEDIA PARTNERSHIP LIMITED London 1
MR MALCOLM JAMES DI GIULIO Accountant London, United Kingdom 2
KARIMA OLA London 1
MRS ELIZABETH DABNEY FRIEND-TONELLI London 1
MR MARC ELIOT FRIEDMAN Finance/Accounting London 11
MR ROBERT DONALD REANY Product Management London, England 1
MR SHANE HENRY KNIGHT London, England 1
ASPIRE TELECOMS LIMITED London 1